Chinese lidar sensor maker Hesai aims to lift output fourfold to meet demand
The company plans to boost production to 2 million units this year from about 502,000 units in 2024, founder and CEO David Li Yifan says.
Renata Simril, President & CEO of the LA84 Foundation, to Receive THE MUSES of the California Science Center Foundation 2025 Woman of the Year Award
LOS ANGELES, April 23, 2025 /PRNewswire/ -- Distinguished youth sports advocate and civic leader, Renata Simril, President & CEO of the LA84 Foundation, will be honored as the 2025 Woman of the Year by THE MUSES of the California Science Center Foundation.
Bitcoin Miner Riot Platforms Gets $100M Credit Facility From Coinbase
Riot Platforms has used a portion of its Bitcoin treasury to secure a $100 million loan from Coinbase's lending arm.
SK Hynix quarterly profit soars 158% to top estimates as chip demand surges on AI boom
South Korea's SK Hynix beat quarterly revenue and operating profit estimates, with demand from artifical intelligence remaining robust.
MRVI INVESTOR ALERT: Kirby McInerney LLP Reminds Maravai Lifesciences Holdings, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit - Maravai LifeSciences ( NASDAQ:MRVI )
NEW YORK, April 23, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP notifies investors of the approaching May 5, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired Maravai Lifesciences Holdings, Inc. ( ...
HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025 - HUTCHMED ( China ) ( NASDAQ:HCM )
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 24, 2025 ( GLOBE NEWSWIRE ) -- HUTCHMED ( China ) Limited ( "HUTCHMED" ) ( Nasdaq/AIM:HCM.
HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 24, 2025 ( GLOBE NEWSWIRE ) -- HUTCHMED ( China ) Limited ( "HUTCHMED" ) ( Nasdaq/AIM:HCM. HKEX:13 ) today announces that new and updated data from several studies of compounds discovered by HUTCHMED including savolitinib, fruquintinib and ...
LOTTE BIOLOGICS Begins Full-Scale Operation of ADC Manufacturing Facility
Signed a contract to manufacture an ADC therapeutic candidate for an Asia-based company Marks the first order following the completion of LOTTE BIOLOGICS' dedicated ADC manufacturing facility in March, signaling the official launch of its ADC CDMO business
South Korea's first-quarter GDP contracts 0.1% as construction activity plunges
Data from the Bank of Korea showed that the drop was mostly due to a fall in construction, with the sector contracting 12.4% year on year.
P/E Ratio Insights for Gilead Sciences - Gilead Sciences ( NASDAQ:GILD )
In the current market session, Gilead Sciences Inc. GILD share price is at $107.00, after a 1.41% increase. Moreover, over the past month, the stock decreased by 2.64%, but in the past year, went up by 62.98%.









